Reyon Pharmaceutical Co (XKRX:102460) 3-Year EBITDA Growth Rate : -2.90% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Reyon Pharmaceutical Co 3-Year EBITDA Growth Rate?

Reyon Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩114.13.

During the past 12 months, Reyon Pharmaceutical Co's average EBITDA Per Share Growth Rate was -41.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -2.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Reyon Pharmaceutical Co was 44.90% per year. The lowest was -58.00% per year. And the median was -6.55% per year.

Competitive Comparison of Reyon Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Reyon Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reyon Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Reyon Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Reyon Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Reyon Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Reyon Pharmaceutical Co (XKRX:102460) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Reyon Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Reyon Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Reyon Pharmaceutical Co (XKRX:102460) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Reyon Pharmaceutical Co Ltd (XKRX:102460) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

416, Yeongdong-daero, 8th floor, Gangnam-gu, Seoul, KOR

Website

http://reyonpharm.co.kr

Reyon Pharmaceutical Co Ltd is a Korea-based pharmaceutical company. It is engaged in the manufacturing and distribution of specialty medicines and raw materials. The main business of the company has been divided into generic drugs, original drugs, and drug substances The key products include eye drops, injection, antibiotics, skeletal muscle relaxants, coagulation drugs, anti-inflammatory enzymes, and blood vessels dialectic drugs, among others.

Reyon Pharmaceutical Co (XKRX:102460) Headlines

No Headlines